Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #5, May 2002
Thimerosal and SV40 â€” one a mercury-based preservative in common inoculations, the other a monkey virus that contaminated injectable and oral versions of the polio vaccine in the 50s and 60s â€” are shaping the future of vaccine litigation.
The Warnings Page: FDA Orders Stronger Warning on Vioxx Label; Consumer Group Petitions for Withdrawal of Arthritus Drug
Not All of Plaintiffs' Ephedra Claims 'Subsumed' Within Liability Doctrine, U.S. District Court Rules
A federal court in Alabama has found that not all of the plaintiffs' claims in a case stemming from the consumption of Metabolife 356 may be subsumed under the Alabama Extended Manufacturer's Liability Doctrine (AEMLD).
A federal judge in West Virginia has refused to remand an OxyContin class action based on his finding that a pharmacy was fraudulently joined to the complaint after being added two weeks after the original was filed.
A federal judge has found that the possibility of attorney's fees and punitive damages coupled with the plaintiffs' claims for damages in an OxyContin case exceeded the statutory minimum necessary to remand the case to state court...
A state court judge in Alaska has reduced the first-ever verdict awarded to a plaintiff allegedly injured by an ephedra-containing product